Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma.

Gang XuXiaoxiang ZhouJiali XingYao XiaoBao JinLejia SunHuayu YangShunda DuHaifeng XuXiaoxiang Zhou

Published in: Cancer cell international (2020)

RASSF1A promoter hypermethylation is a promising biomarker for the diagnosis of HCC from tissue and peripheral blood, and is an emerging therapeutic target against HCC.

Keyphrases

peripheral blood
dna methylation
transcription factor
gene expression
bioinformatics analysis